PeptiStar Inc. is a technology-based CDMO established in 2017 in Osaka, Japan, specializing in peptide and oligonucleotide API development and manufacturing. The company was awarded '2025 CDMO of the Year' by Exelixis and is recognized as the largest-class peptide CDMO in Asia. PeptiStar operates two GMP manufacturing buildings with Class 100,000 controlled areas, housing 300L filter reactors and 500L lyophilizers, capable of handling samples from a few milligrams to several dozen kilograms.
peptide API manufacturing, oligonucleotide API manufacturing, microwave SPPS, STag-PS technology, SYNCSOL continuous chromatography, mixer-type lyophilization
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.